Bonnefoy Luc 4
4 · Bausch & Lomb Corp · Filed Feb 20, 2026
Research Summary
AI-generated summary of this filing
Bausch & Lomb (BLCO) President Luc Bonnefoy Receives Award
What Happened
Luc Bonnefoy, President, Surgical for Bausch & Lomb (BLCO), was reported as acquiring 10,202 common shares on Feb 18, 2026. The shares were recorded as an award/other acquisition at $0.00 (total reported value $0) and reflect performance stock units (PSUs) that met their performance conditions.
Key Details
- Transaction date: 2026-02-18; Filing date: 2026-02-20 (timely — within the usual 2-business-day Form 4 window).
- Reported acquisition: 10,202 shares at $0.00 per share (code A — award/grant).
- Shares owned after transaction: Not specified in this filing.
- Footnote: These are common shares underlying PSUs originally granted Mar 1, 2023 under the 2022 Omnibus Incentive Plan; the PSUs satisfied performance conditions on Feb 18, 2026 and the earned PSUs will vest on Mar 1, 2026, generally conditioned on continued employment.
Context
PSUs are performance-based equity awards. This filing reports that the performance conditions were met, converting the PSUs into shares to be vested March 1, 2026 (subject to employment). The $0 acquisition price reflects an earned award rather than a market purchase or sale — it is compensation, not a cash investment or divestment by the insider.
Insider Transaction Report
- Award
Common Shares, No Par Value
[F1]2026-02-18+10,202→ 87,564 total
Footnotes (1)
- [F1]Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.